This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maesawa, C. Articles by Satodate, R. Search for Related Content PubMed PubMed Citation Articles by Maesawa, C. Articles by Satodate, R.

Inactivation of the CDKN2 Gene by Homozygous Deletion and de Novo Methylation Is Associated with Advanced Stage Esophageal Squamous Cell Carcinoma¹

Departments of Pathology [C. M., G. T., S. N., Ke. S., R. S.] and Surgery [S. O., K. I., M. T., N. S., Ka. S.], Iwate Medical University School of Medicine, Uchimaru 19-1, 020 Morioka, Japan

We examined the genomic status of the CDKN2 gene including de novo methylation of 5' CpG islands in primary and metastatic tumor samples from 31 patients with esophageal squamous cell carcinoma. One somatic frame shift mutation (1 of 31; 3.2%) was identified by PCR-single strand conformational polymorphism analysis and DNA sequencing. Homozygous deletion and de novo methylation of the gene were confirmed in 5 (16%) and 6 (19%) of 31 patients, respectively. Homozygous deletion and de novo methylation were significantly associated with silencing of gene expression (P < 0.01). Aberrations of the CDKN2 gene were detected in tumors with lymph node metastasis and muscular invasion (12 of 22; 54%) and in none of stage I tumors (0 of 9, 0%; P < 0.05). These results suggest that homozygous deletion and de novo methylation are predominant mechanisms of inactivation of the CDKN2 gene and may be associated with metastatic and invasive phenotypes of esophageal squamous cell carcinoma.

¹ This work was supported by a Grant-in-Aid for Cancer Research (S6-32 and S7-1) from the Ministry of Health and Welfare, Japan.

² To whom requests for reprints should be addressed.

Received 5/21/96. Accepted 7/16/96.

This article has been cited by other articles:

				E. J. Chapman, P. Harnden, P. Chambers, C. Johnston, and M. A. Knowles Comprehensive Analysis of CDKN2A Status in Microdissected Urothelial Cell Carcinoma Reveals Potential Haploinsufficiency, a High Frequency of Homozygous Co-deletion and Associations with Clinical Phenotype Clin. Cancer Res., August 15, 2005; 11(16): 5740 - 5747. [Abstract] [Full Text] [PDF]

				C. F. Eisenberger, W. T. Knoefel, M. Peiper, P. Merkert, E. F. Yekebas, P. Scheunemann, K. Steffani, N. H. Stoecklein, S. B. Hosch, and J. R. Izbicki Squamous Cell Carcinoma of the Esophagus Can Be Detected by Microsatellite Analysis in Tumor and Serum Clin. Cancer Res., September 15, 2003; 9(11): 4178 - 4183. [Abstract] [Full Text] [PDF]

				T. Tokugawa, H. Sugihara, T. Tani, and T. Hattori Modes of Silencing of p16 in Development of Esophageal Squamous Cell Carcinoma Cancer Res., September 1, 2002; 62(17): 4938 - 4944. [Abstract] [Full Text] [PDF]

				S. Nishizuka, H. Tsujimoto, and E. J. Stanbridge Detection of Differentially Expressed Genes in HeLa Fibroblast Hybrids Using Subtractive Suppression Hybridization Cancer Res., June 1, 2001; 61(11): 4536 - 4540. [Abstract] [Full Text] [PDF]

				I. Sturm, H. Petrowsky, R. Volz, M. Lorenz, S. Radetzki, T. Hillebrand, G. Wolff, S. Hauptmann, B. Dorken, and P. T. Daniel Analysis of p53/BAX/p16ink4a/CDKN2 in Esophageal Squamous Cell Carcinoma: High BAX and p16ink4a/CDKN2 Identifies Patients With Good Prognosis J. Clin. Oncol., April 15, 2001; 19(8): 2272 - 2281. [Abstract] [Full Text] [PDF]

				C.S. Chim, R. Liang, C.Y.Y. Tam, and Y.L. Kwong Methylation of p15 and p16 Genes in Acute Promyelocytic Leukemia: Potential Diagnostic and Prognostic Significance J. Clin. Oncol., April 1, 2001; 19(7): 2033 - 2040. [Abstract] [Full Text] [PDF]

				I. H. N. Wong, Y. M. Dennis Lo, W. Yeo, W. Y. Lau, and P. J. Johnson Frequent p15 Promoter Methylation in Tumor and Peripheral Blood from Hepatocellular Carcinoma Patients Clin. Cancer Res., September 1, 2000; 6(9): 3516 - 3521. [Abstract] [Full Text]

				I. H. N. Wong, M. H. L. Ng, D. P. Huang, and J. C. K. Lee Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: potential prognostic implications Blood, March 15, 2000; 95(6): 1942 - 1949. [Abstract] [Full Text] [PDF]

				E. P. Xing, Y. Nie, Y. Song, G.-Y. Yang, Y. C. Cai, L.-D. Wang, and C. S. Yang Mechanisms of Inactivation of p14ARF, p15INK4b, and p16INK4a Genes in Human Esophageal Squamous Cell Carcinoma Clin. Cancer Res., October 1, 1999; 5(10): 2704 - 2713. [Abstract] [Full Text] [PDF]

				E. P. Xing, Y. Nie, L.-D. Wang, G.-Y. Yang, and C. S. Yang Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China Carcinogenesis, January 1, 1999; 20(1): 77 - 84. [Abstract] [Full Text] [PDF]